Clinical Trial Update: Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine [Phase 2]

View source ↗

Summary

Reports the completion of a Phase 2 trial assessing the efficacy and safety of BHV-2100 for the acute treatment of migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• BHV-2100

Snippet

Sponsor: Biohaven Therapeutics Ltd. | Conditions: Migraine | Phase 2 | Status: COMPLETED